Pacific Biosciences Denies Helicos' Infringement Claims | GenomeWeb

This article has been updated to correct the anticipated commercial launch date for Pacific Biosciences' system.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today said that it believes the patent infringement claims brought against the company last week by Helicos Biosciences are without merit and that it intends to vigorously defend against the claims.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.